EXCOR Pediatric Ventricular Assist Device
Berlin Heart, Inc. · Decision date Sep 1, 2026
What did the FDA approve?
The FDA's decision record for P160035/S058, dated 2026-09-01, lists a normal 180-day track supplement for the EXCOR Pediatric Ventricular Assist Device (product code DSQ, ventricular assist bypass, applicant Berlin Heart, Inc.). The stated purpose is approval of a shortened trocar in the de-airing set, filed under change design/components/specifications/material. That describes a component modification within an existing device rather than a new system approval.
The supplement number indicates this action belongs to the original PMA P160035, and the filing concerns a specification or material change to one part. The record does not state trocar dimensions, material, de-airing procedure details, testing performed or review basis, so the rationale for the modification cannot be described from the supplied fields. The listed approval purpose is the agency's stated action and is not independent evidence of safety or clinical effectiveness for the changed component or the system.
FDA approval order statement
Approval for a shortened trocar in the de-airing set
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 1, 2026
- FDA change category
- Change Design/Components/Specifications/Material
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P160035/S058
- Regulatory pathway
- PMA supplement
- Applicant
- Berlin Heart, Inc.
- Product code
- DSQ
- Decision code
- APPR
- Decision date
- Sep 1, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventricular (assist) bypass.
- Applicant
- Berlin Heart, Inc.
- Product code
- DSQ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P160035. Subsequent supplements may change the device or its indications.
FDA decision timeline
P160035 · Original PMA
EXCOR Pediatric Ventricular Assist Device
P160035/S058 received
Application receipt date recorded by FDA.
P160035/S058 · FDA decision
Normal 180 Day Track
P160035/S057 · Related supplement
EXCOR Pediatric Ventricular Assist Device
P160035/S056 · Related supplement
EXCOR Pediatric VAD
P160035/S060 · Related supplement
EXCOR Pediatric Ventricular Assist Device
P160035/S061 · Related supplement
EXCOR Pediatric VAD
P160035/S054 · Related supplement
EXCOR Pediatric Ventricular Assist Device
Timeline entries are records held by MedtechLedger for P160035. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160035
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Berlin Heart, Inc. | PMA approval | Jun 6, 2017 | FDA | |
EXCOR Pediatric Ventricular Assist DeviceP160035/S057 | Berlin Heart, Inc. | PMA supplement | Oct 1, 2026 | FDA |
EXCOR Pediatric VADP160035/S056 | Berlin Heart, Inc. | PMA supplement | Oct 14, 2026 | FDA |
EXCOR Pediatric Ventricular Assist DeviceP160035/S060 | Berlin Heart, Inc. | PMA supplement | Oct 23, 2026 | FDA |
EXCOR Pediatric VADP160035/S061 | Berlin Heart, Inc. | PMA supplement | Oct 28, 2026 | FDA |
EXCOR Pediatric Ventricular Assist DeviceP160035/S054 | Berlin Heart, Inc. | PMA supplement | Oct 30, 2026 | FDA |
Explore the linked device profile
Other records with product code DSQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CentriMag Circulatory Support SystemP170038/S034 | Abbott | PMA supplement | Oct 30, 2026 | FDA |
HeartMate 3 Left Ventricular Assist SystemP160054/S136 | ABBOTT MEDICAL | PMA supplement | Oct 19, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S033 | Abbott | PMA supplement | Oct 2, 2026 | FDA |
HeartMate II LVASP060040/S128 | ABBOTT MEDICAL | PMA supplement | Oct 1, 2026 | FDA |
HeartMate 3 LVASP160054/S135 | ABBOTT MEDICAL | PMA supplement | Oct 1, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Berlin Heart, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 9391 Grogan'S Mill Rd., Suite A-6, The Woodlands, TX, 77380
Sources and methodology
- Original FDA record: P160035/S058
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





